Reckitt Benckiser’s shares rose after the company said adjusted profit beat market expectations, despite lower sales, as it continues to progress with its turnaround plans. Shares in morning trade ...

As trade war intensifies, Reckitt may be more exposed than some rivals Some investors fear Reckitt may be forced to raise its prices in the United States or face higher costs as its low ...

Abbott was down 2.7% at 1:54 p.m. in New York after paring morning losses, while Reckitt’s shares fell as much as 5.6% in London before closing down 1.7%. Both early declines were the biggest in ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in ...

Reckitt has shown a medium-term uptrend since April 2024, outperforming peers, but litigation risks from Mead Johnson remain substantial, making the stock a hold. Reckitt's strategic focus on high ...

Reckitt Benckiser Group plc (OTCMKTS:RBGLY – Get Free Report) has received an average recommendation of “Buy” from the eight analysts that are currently covering the company, Marketbeat reports.

Reckitt Benckiser is continuing to assess options for its nutrition operations housing the Mead Johnson infant-formula business. After describing nutrition as “non-core” in July as part of a ...

NEW YORK, NY / ACCESS Newswire / February 26, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Reckitt Benckiser Group plc ("Reckitt Benckiser Group plc") (OTC ...

(Bloomberg) -- Abbott Laboratories and Reckitt Benckiser Group Plc shares fell as a judge ordered a new trial after rejecting a verdict that had cleared the companies of liability over claims they ...

Reckitt Benckiser Group plc's ( LON:RKT ) dividend will be increasing from last year's payment of the same period to... Reckitt Benckiser Group PLC (RBGLY) reports robust profit growth and shareholder ...